Accolade ACCD

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.00 (+0.00%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Accolade (ACCD)
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Key Insights

Critical company metrics and information
  • Latest Closing Price

    $6.97
  • Market Cap

    $569.30 Million
  • Price-Earnings Ratio

    -3.11
  • Total Outstanding Shares

    81.99 Million Shares
  • Total Employees

    2,400
  • Dividend

    No dividend
  • IPO Date

    July 2, 2020
  • SIC Description

    Services-business Services, Nec
  • Primary Exchange

    NASDAQ
  • Type

    Common Stock
  • Headquarters

    660 w. germantown pike suite 500, Plymouth meeting, PA, 19462
  • Homepage

    https://www.accolade.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

December 1, 2023 to November 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$-6.76 Million
Net Cash Flow From Investing Activities$-43.55 Million
Net Cash Flow From Investing Activities, Continuing$-43.55 Million
Net Cash Flow, Continuing$-44.09 Million
Net Cash Flow$-44.09 Million
Net Cash Flow From Operating Activities$-6.76 Million

Income Statement

December 1, 2023 to November 30, 2024
MetricValue
Basic Average Shares$239.17 Million
Benefits Costs and Expenses$625.25 Million
Revenues$446.72 Million
Other Operating Expenses$356.44 Million
Net Income/Loss$-180.30 Million
Net Income/Loss Attributable To Parent$-180.30 Million

Comprehensive Income

December 1, 2023 to November 30, 2024
MetricValue
Comprehensive Income/Loss$-180.27 Million
Other Comprehensive Income/Loss$-180.27 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss Attributable To Parent$-180.27 Million

Balance Sheet

December 1, 2023 to November 30, 2024
MetricValue
Current Assets$272.45 Million
Noncurrent Liabilities$230.87 Million
Accounts Payable$10.34 Million
Wages$33.45 Million
Noncurrent Assets$375.00 Million
Equity$313 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ACCD from trusted financial sources